Critical appeal for Type O-negative donors
Heavy usage depletes local blood supply
Hoxworth Blood Center, University of Cincinnati is releasing a critical appeal for type O- negative blood. All eligible individuals are being asked to donate blood immediately.
“We are asking all eligible individuals with Type O- negative blood to donate as soon as possible,” reports Alecia Lipton, Hoxworth spokesperson. “Blood is being distributed to local hosopitals faster than it can be collected, and we cannot rely on acquiring blood from other communities at this time.”
Type O- negative blood is extremely valuable since it can be transfused to any other blood type in an emergency.
It is critical to have a healthy supply of O- negative blood on hand, according to Lipton, because it can be transfused to any other blood type in the event of an emergency or mass trauma.
“Recent heavy usage due to traumas and organ transplants, coupled with low donor turnout in recent weeks, has drained local supply of O- negative blood,” said David Oh, MD, Chief Medical Officer of Hoxworth Blood Center. “We urge the community to schedule a donation as soon as possible to ensure that patients in need will have lifesaving blood products available when needed."
Appointments are highly encouraged at this time, and masks are required. To schedule a donation, call (513) 451-0910 or visit www.hoxworth.org.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati was founded in 1938 and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 90,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.